425 results on '"Treweek, S."'
Search Results
2. Trial Forge Guidance 4: a guideline for reporting the results of randomised Studies Within A Trial (SWATs)
- Author
-
Arundel, C. E., Clark, L. K., Parker, A., Beard, D., Coleman, E., Cooper, C., Devane, D., Eldridge, S., Galvin, S., Gillies, K., Hewitt, C. E., Sutton, C., Torgerson, D. J., and Treweek, S.
- Published
- 2024
- Full Text
- View/download PDF
3. The development and acceptability of an educational and training intervention for recruiters to neonatal trials: the TRAIN project
- Author
-
Smith, V., Delaney, H., Hunter, A., Torgerson, D., Treweek, S., Gamble, C., Mills, N., Stanbury, K., Dempsey, E., Daly, M., O’Shea, J., Weatherup, K., Deshpande, S., Ryan, M. A., Lowe, J., Black, G., and Devane, D.
- Published
- 2023
- Full Text
- View/download PDF
4. Value and engagement: what can clinical trials learn from techniques used in not-for-profit marketing?
- Author
-
Mitchell, E. J., Sprange, K., Treweek, S., and Nixon, E.
- Published
- 2022
- Full Text
- View/download PDF
5. Associations between patient factors and successful colon capsule endoscopy – A prospective cohort study
- Author
-
MacLeod, C., primary, Foxton, A., additional, Wilson, P., additional, Treweek, S., additional, and Watson, A. J. M., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Staff training to improve participant recruitment into surgical randomised controlled trials: A feasibility study within a trial (SWAT) across four host trials simultaneously
- Author
-
Parker, A, Arundel, C, Mills, N, Rooshenas, L, Jepson, M, Donovan, JL, Blazeby, JM, Coleman, E, Clark, L, Doherty, L, Hewitt, CE, Partha Sarathy, P, Beard, D, Bower, P, Brealey, S, Brocklehurst, P, Cooper, C, Croft, J, Culliford, L, Dias, J, Devane, D, Eldridge, S, Emsley, R, Galvin, S, Gemperle-Mannion, E, Jayne, DG, Metcalfe, AJ, Montgomery, A, Rangan, A, Sutton, CJ, Tharmanathan, P, Treweek, S, and Torgerson, D
- Subjects
General Medicine - Abstract
Objective To test the feasibility of undertaking a simultaneous Study Within A Trial (SWAT) to train staff who recruit participants into surgical randomised controlled trials (RCTs), by assessing key uncertainties around recruitment, randomisation, intervention delivery and data collection. Study design and setting Twelve surgical RCTs were eligible. Interested sites (clusters) were randomised 1:1, with recruiting staff (surgeons and nurses) offered training or no training. The primary outcome was the feasibility of recruiting sites across multiple surgical trials simultaneously. Secondary outcomes included numbers/types of staff enrolled, attendance at training, training acceptability, confidence in recruiting and participant recruitment rates six months later. Results Four RCTs (33%) comprising 91 sites participated. Of these, 29 sites agreed to participate (32%) and were randomised to intervention (15 sites, 29 staff) or control (14 sites, 29 staff). Research nurses attended and found the training to be acceptable; no surgeons attended. In the intervention group, there was evidence of increased confidence when pre- and post- training scores were compared (mean difference in change 1.42; 95% CI 0.56, 2.27; p = 0.002). There was no effect on recruitment rate. Conclusion It was feasible to randomise sites across four surgical RCTs in a simultaneous SWAT design. However, as small numbers of trials and sites participated, and no surgeons attended training, strategies to improve these aspects are needed for future evaluations.
- Published
- 2022
- Full Text
- View/download PDF
7. ELECtric Tibial nerve stimulation to Reduce Incontinence in Care homes: protocol for the ELECTRIC randomised trial
- Author
-
Booth, J., Aucott, L., Cotton, S., Goodman, C., Hagen, S., Harari, D., Lawrence, M., Lowndes, A., Macaulay, L., MacLennan, G., Mason, H., McClurg, D., Norrie, J., Norton, C., O’Dolan, C., Skelton, D. A., Surr, C., and Treweek, S.
- Published
- 2019
- Full Text
- View/download PDF
8. Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma
- Author
-
Murchie, P., Masthoff, J., Walter, F. M., Rahman, K., Allan, J. L., Burrows, N., Proby, C., Lee, A. J., Johnston, M., Durrani, A., Depasquale, I., Brant, B., Neilson, A., Meredith, F., Treweek, S., Hall, S., and McDonald, A.
- Published
- 2019
- Full Text
- View/download PDF
9. Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood
- Author
-
van Cruchten, Remco, van As, Daniël, Glennon, Jeffrey, van Engelen, Baziel, Okkersen, K, Jimenez-Moreno, C, Wenninger, S, Daidj, F, Cumming, S, Littleford, R, Monckton, D, Lochmüller, H, Catt, M, Faber, C, Hapca, A, Donnan, P, Gorman, G, Bassez, G, Schoser, B, Knoop, H, Treweek, S, Wansink, Derick, Impens, Francis, Gabriels, Ralf, Claeys, Tine, Ravel-Chapuis, Aymeric, Jasmin, Bernard, Mahon, Niamh, Nieuwenhuis, Sylvia, Martens, Lennart, Novak, Petr, Furling, Denis, Baak, Arie, Gourdon, Genevieve, Mackenzie, Alex, Martinat, Cecile, Neault, Nafisa, Roos, Andreas, Duchesne, Elise, Salz, Renee, Thompson, Rachel, Baghdoyan, Sandrine, Varghese, Anu, Blom, Paul, Spendiff, Sally, Manta, Alexander, Medical Psychology, APH - Mental Health, Radboud University Medical Center [Nijmegen], University College Dublin [Dublin] (UCD), Donders Institute for Brain, Cognition and Behaviour, Radboud University [Nijmegen], Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Newcastle University [Newcastle], Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Vlaams Instituut voor Biotechnologie [Ghent, Belgique] (VIB), Universiteit Gent = Ghent University [Belgium] (UGENT), Centre de recherche en Myologie – U974 SU-INSERM, and Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)
- Subjects
Lifestyle intervention ,Myotonic dystrophy type 1 ,[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology ,Therapeutic Response ,Gene Expression ,Peripheral blood ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,Nerve Tissue Proteins ,General Medicine ,Biomarker ,HSP40 Heat-Shock Proteins ,Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9] ,Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] ,All institutes and research themes of the Radboud University Medical Center ,[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,Humans ,Myotonic Dystrophy ,RNA, Messenger ,RNA-seq ,Carrier Proteins ,Trinucleotide Repeat Expansion ,Nanomedicine Radboud Institute for Molecular Life Sciences [Radboudumc 19] - Abstract
Background Myotonic dystrophy type 1 (DM1) is an incurable multisystem disease caused by a CTG-repeat expansion in the DM1 protein kinase (DMPK) gene. The OPTIMISTIC clinical trial demonstrated positive and heterogenous effects of cognitive behavioral therapy (CBT) on the capacity for activity and social participations in DM1 patients. Through a process of reverse engineering, this study aims to identify druggable molecular biomarkers associated with the clinical improvement in the OPTIMISTIC cohort. Methods Based on full blood samples collected during OPTIMISTIC, we performed paired mRNA sequencing for 27 patients before and after the CBT intervention. Linear mixed effect models were used to identify biomarkers associated with the disease-causing CTG expansion and the mean clinical improvement across all clinical outcome measures. Results We identified 608 genes for which their expression was significantly associated with the CTG-repeat expansion, as well as 1176 genes significantly associated with the average clinical response towards the intervention. Remarkably, all 97 genes associated with both returned to more normal levels in patients who benefited the most from CBT. This main finding has been replicated based on an external dataset of mRNA data of DM1 patients and controls, singling these genes out as candidate biomarkers for therapy response. Among these candidate genes were DNAJB12, HDAC5, and TRIM8, each belonging to a protein family that is being studied in the context of neurological disorders or muscular dystrophies. Across the different gene sets, gene pathway enrichment analysis revealed disease-relevant impaired signaling in, among others, insulin-, metabolism-, and immune-related pathways. Furthermore, evidence for shared dysregulations with another neuromuscular disease, Duchenne muscular dystrophy, was found, suggesting a partial overlap in blood-based gene dysregulation. Conclusions DM1-relevant disease signatures can be identified on a molecular level in peripheral blood, opening new avenues for drug discovery and therapy efficacy assessments.
- Published
- 2022
- Full Text
- View/download PDF
10. Another Brick in the Wall … no More! Breaking the Sex Bias
- Author
-
De Paoli, M., primary, Gardner, H.R., additional, and Treweek, S., additional
- Published
- 2022
- Full Text
- View/download PDF
11. Predictors of recruitment and retention in randomized controlled trials of behavioural smoking cessation interventions: a systematic review and meta-regression analysis
- Author
-
Bricca, A., Swithenbank, Z., Scott, N., Treweek, S., Johnston, M., Black, N., Hartmann-Boyce, J., West, R., Michie, S., Bruin, M. de, Bricca, A., Swithenbank, Z., Scott, N., Treweek, S., Johnston, M., Black, N., Hartmann-Boyce, J., West, R., Michie, S., and Bruin, M. de
- Abstract
Contains fulltext : 249002.pdf (Publisher’s version ) (Open Access), AIM: To investigate predictors of participant eligibility, recruitment and retention in behavioural randomized controlled trials (RCTs) for smoking cessation. METHOD: Systematic review and pre-specified meta-regression analysis of behavioural RCTs for smoking cessation including adult (≥ 18-year-old) smokers. The pre-specified predictors were identified through a literature review and experts' consultation and included participant, trial and intervention characteristics and recruitment and retention strategies. Outcome measures included eligibility rates (proportion of people eligible for the trials), recruitment rates, retention rates and differential retention rates. RESULTS: A total of 172 RCTs with 89 639 participants. Eligibility [median 57.6%; interquartile range (IQR) = 34.7-83.7], recruitment (median 66.4%; IQR = 42.7-85.2) and retention rates (median 80.5%; IQR = 68.5-89.5) varied considerably across studies. For eligibility rates, the recruitment strategy appeared not to be associated with eligibility rates. For recruitment rates, use of indirect recruitment strategies (e.g. public announcements) [odds ratio (OR) = 0.30, 95% confidence interval (CI) = 0.11-0.82] and self-help interventions (OR = 0.14, 95% CI = 0.03-0.67) were associated with lower recruitment rates. For retention rates, higher retention was seen if the sample had ongoing physical health condition/s (OR = 1.66, 95% CI = 1.04-2.63), whereas lower retention was seen amongst primarily female samples (OR = 0.83, 95% CI = 0.71-0.98) and those motivated to quit smoking (OR = 0.74, 95% CI = 0.55-0.99) when indirect recruitment methods were used (OR = 0.60, 95% CI = 0.38-0.97) and at longer follow-up assessments (OR = 0.83, 95% CI = 0.79-0.87). For differential retention, higher retention in the intervention group occurred when the intervention but not comparator group received financial incentives for smoking cessation (OR = 1.35, 95% CI = 1.02-1.77). CONCLUSIONS: In randomized controlled trials o
- Published
- 2022
12. Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice
- Author
-
Dawson, S, Banister, K, Biggs, K, Cotton, S, Devane, D, Gardner, H, Gillies, K, Gopalakrishnan, G, Isaacs, T, Khunti, K, Nichol, A, Parker, A, Russell, AM, Shepherd, V, Shiely, F, Shorter, G, Starling, B, Williams, H, Willis, A, Witham, MD, Treweek, S, Dawson, S, Banister, K, Biggs, K, Cotton, S, Devane, D, Gardner, H, Gillies, K, Gopalakrishnan, G, Isaacs, T, Khunti, K, Nichol, A, Parker, A, Russell, AM, Shepherd, V, Shiely, F, Shorter, G, Starling, B, Williams, H, Willis, A, Witham, MD, and Treweek, S
- Abstract
Randomised trials, especially those intended to directly inform clinical practice and policy, should be designed to reflect all those who could benefit from the intervention under test should it prove effective. This does not always happen. The UK National Institute for Health and Care Research (NIHR) INCLUDE project identified many groups in the UK that are under-served by trials, including ethnic minorities.This guidance document presents four key recommendations for designing and running trials that include the ethnic groups needed by the trial. These are (1) ensure eligibility criteria and recruitment pathway do not limit participation in ways you do not intend, (2) ensure your trial materials are developed with inclusion in mind, (3) ensure staff are culturally competent and (4) build trusting partnerships with community organisations that work with ethnic minority groups. Each recommendation comes with best practice advice, public contributor testimonials, examples of the inclusion problem tackled by the recommendation, or strategies to mitigate the problem, as well as a collection of resources to support implementation of the recommendations.We encourage trial teams to follow the recommendations and, where possible, evaluate the strategies they use to implement them. Finally, while our primary audience is those designing, running and reporting trials, we hope funders, grant reviewers and approvals agencies may also find our guidance useful.
- Published
- 2022
13. Trial Forge Guidance 3: randomised trials and how to recruit and retain individuals from ethnic minority groups-practical guidance to support better practice (vol 23, 672, 2022)
- Author
-
Dawson, S, Banister, K, Biggs, K, Cotton, S, Devane, D, Gardner, H, Gillies, K, Gopalakrishnan, G, Isaacs, T, Khunti, K, Nichol, A, Parker, A, Russell, AM, Shepherd, V, Shiely, F, Shorter, G, Starling, B, Williams, H, Willis, A, Witham, MD, Treweek, S, Dawson, S, Banister, K, Biggs, K, Cotton, S, Devane, D, Gardner, H, Gillies, K, Gopalakrishnan, G, Isaacs, T, Khunti, K, Nichol, A, Parker, A, Russell, AM, Shepherd, V, Shiely, F, Shorter, G, Starling, B, Williams, H, Willis, A, Witham, MD, and Treweek, S
- Published
- 2022
14. The Achieving Self-directed Integrated Cancer Aftercare Intervention for Detection of Recurrent and Second Primary Melanoma in Survivors of Melanoma: Pilot Randomized Controlled Trial.
- Author
-
Murchie, P, Constable, L, Hall, S, Brant, W, Allan, J, Johnston, M, Masthoff, J, Lee, A, Treweek, S, Ayansina, D, Proby, C, Rahman, K, Walter, F, Burrows, N, Durrani, A, Maclennan, G, Murchie, P, Constable, L, Hall, S, Brant, W, Allan, J, Johnston, M, Masthoff, J, Lee, A, Treweek, S, Ayansina, D, Proby, C, Rahman, K, Walter, F, Burrows, N, Durrani, A, and Maclennan, G
- Abstract
BACKGROUND: Melanoma is common with increasing incidence. Guidelines recommend monthly total skin self-examinations (TSSEs) by survivors to detect recurrent and new primary melanomas. TSSE is underperformed despite evidence of benefit. OBJECTIVE: This study compares the effect on psychological well-being and TSSE practice of a self-directed digital intervention with treatment as usual in patients treated for a first stage 0 to IIC primary cutaneous melanoma within the preceding 60 months. METHODS: This randomized clinical trial was conducted at 2 UK National Health Service hospitals (Aberdeen Royal Infirmary, Grampian, and Addenbrooke's, Cambridge). Adults (≥18 years) diagnosed with a first 0 to IIC primary cutaneous melanoma were randomized to receive Achieving Self-directed Integrated Cancer Aftercare (ASICA), a tablet-based intervention prompting and supporting TSSE in survivors of melanoma, or to usual care. The hypothesis was that ASICA would increase TSSE practice in users affected by melanoma and compared with controls without affecting psychological well-being. The main primary outcomes were melanoma worry (Melanoma Worry Scale), anxiety and depression (Hospital Anxiety and Depression Scale), and quality of life (EQ-5D-5L) as well as secondary outcomes collected using postal questionnaires 3, 6, and 12 months following randomization. RESULTS: A total of 240 recruits were randomized (1:1) into the ASICA (n=121, 50.4%) or control (n=119, 49.6%) groups. There were no significant differences between groups for melanoma worry at 12 months (mean difference: 0.12, 95% CI -0.6 to 0.84; P=.74), 3 months (0.23, 95% CI -0.31 to 0.78; P=.40), or 6 months (-0.1, 95% CI -0.7 to 0.51; P=.76). The ASICA group had lower anxiety scores at 12 months (-0.54, 95% CI -1.31 to 0.230; P=.17), 3 months (-0.13, 95% CI -0.79 to 0.54; P=.71), and significantly at 6 months (-1.00, 95% CI -1.74 to -0.26; P=.009). Depression scores were similar, being lower at 12 months (-0.44, 95% CI -1.
- Published
- 2022
15. Barriers, facilitators and pathways of a lung cancer screening (LCS) programme: COBELT co-design
- Author
-
Brown, L., Frank Sullivan, Treweek, S., Haddow, A., Mountain, R., Selby, C., and Beusekom, M.
- Subjects
Public Health, Environmental and Occupational Health - Abstract
Lung cancer (LC) is one of the most common causes of cancer death globally. Adults aged 55+, (ex)-smokers and living in areas of deprivation are at greater risk from lung cancer. Leading to a 20% decrease in mortality rates, screening with Low Dose CT (LDCT) is a promising means of detecting LC early. Autoantibody biomarker blood tests may play a role in identifying people suitable for LDCT screening, forming a national LCS programme. To increase the likelihood of the success of such a programme, suitable ways of providing the service must firstly be identified. A 2-phase co-design process, with 2 population groups. Group 1-Aged 55+, (ex)-smoker, high deprivation (N = 39). Group 2-Health and community professionals (N = 16). Phase 1: Interviews and focus groups. Conversations focussed on barriers, facilitators and potential pathways for the uptake and provision of a biomarker blood test and LCS. Phase 2: Interactive surveys (offline/online), focussing on the prioritisation of key barriers and solution generation. Qualitative data was transcribed and analysed using thematic analysis. Descriptive statistics were generated for quantitative data. Phase 1 identified key barriers, facilitators and pathways for uptake and provision. Service users indicated options for uptake and a means to embed the programme in the community as essential. From the perspective of providers, capacity and time for provision were key. Phase 2 found a home test kit was the preferred method of blood test for service users (independently or with assistance). Service providers leaned towards provision via venesection. Barriers were ranked by service users, the most dominant barrier was Fear of test result. Working in a collaborative manner has led to the identification of new knowledge and insights regarding the best means to target a future LCS programme to those who may benefit most. Future implementation of such a programme should consider the results from this study. This is a CSO funded project. Key messages This process has illuminated key barriers, facilitators and pathway options that could improve the implementation of a LCS programme, using an autoantibody blood test to identify LDCT candidates. Measures to overcome barriers from both the perspective of the service users and providers are necessary to ensure the success of the LCS programme.
- Published
- 2021
- Full Text
- View/download PDF
16. Colorectal adenomas and diabetes: implications for disease prevention
- Author
-
Steele, R. J. C., Anderson, A. S., Macleod, M., Craigie, A. M., Caswell, S., Belch, J., and Treweek, S.
- Published
- 2015
- Full Text
- View/download PDF
17. Cancer prevention through weight control—where are we in 2020?
- Author
-
Anderson, AS, Renehan, AG, Saxton, JM, Bell, J, Cade, J, Cross, AJ, King, A, Riboli, E, Sniehotta, F, Treweek, S, Martin, RM, Beeken, R, and Mitrou, G
- Subjects
Lifestyle modification ,Cancer Research ,Overweight ,B400 ,COLORECTAL-CANCER ,Cancer prevention ,0302 clinical medicine ,Weight loss ,UK NIHR Cancer and Nutrition Collaboration (Population Health Stream) ,Neoplasms ,Epidemiology ,Medicine ,INSULIN-RESISTANCE ,Public health ,cancer prevention ,public health ,POSTMENOPAUSAL WOMEN ,Oncology ,LIFE-STYLE INTERVENTION ,030220 oncology & carcinogenesis ,Perspective ,MENDELIAN RANDOMIZATION ,ICEP ,medicine.symptom ,Life Sciences & Biomedicine ,medicine.medical_specialty ,MEDLINE ,B100 ,B300 ,B700 ,1117 Public Health and Health Services ,03 medical and health sciences ,Weight Loss ,BREAST-CANCER ,Animals ,Humans ,1112 Oncology and Carcinogenesis ,Oncology & Carcinogenesis ,Intensive care medicine ,Exercise ,Science & Technology ,business.industry ,Cancer ,A100 ,medicine.disease ,Obesity ,BODY-MASS INDEX ,PHYSICAL-ACTIVITY ,RISK-FACTORS ,lifestyle modification ,business ,Risk Reduction Behavior - Abstract
Growing data from epidemiological studies highlight the association between excess body fat and cancer incidence, but good indicative evidence demonstrates that intentional weight loss, as well as increasing physical activity, offers much promise as a cost-effective approach for reducing the cancer burden. However, clear gaps remain in our understanding of how changes in body fat or levels of physical activity are mechanistically linked to cancer, and the magnitude of their impact on cancer risk. It is important to investigate the causal link between programmes that successfully achieve short-term modest weight loss followed by weight-loss maintenance and cancer incidence. The longer-term impact of weight loss and duration of overweight and obesity on risk reduction also need to be fully considered in trial design. These gaps in knowledge need to be urgently addressed to expedite the development and implementation of future cancer-control strategies. Comprehensive approaches to trial design, Mendelian randomisation studies and data-linkage opportunities offer real possibilities to tackle current research gaps. In this paper, we set out the case for why non-pharmacological weight-management trials are urgently needed to support cancer-risk reduction and help control the growing global burden of cancer.
- Published
- 2021
- Full Text
- View/download PDF
18. Supporting postpartum weight loss in women living in deprived communities: design implications for a randomised control trial
- Author
-
Craigie, A M, Macleod, M, Barton, K L, Treweek, S, and Anderson, A S
- Published
- 2011
- Full Text
- View/download PDF
19. Why trials lose participants: A multitrial investigation of participants perspectives using the theoretical domains framework
- Author
-
Newlands, R, Duncan, E, Presseau, J, Treweek, S, Lawrie, L, Bower, P, Elliott, J, Francis, J, MacLennan, G, Ogden, M, Wells, M, Witham, MD, Young, B, Gillies, K, Newlands, R, Duncan, E, Presseau, J, Treweek, S, Lawrie, L, Bower, P, Elliott, J, Francis, J, MacLennan, G, Ogden, M, Wells, M, Witham, MD, Young, B, and Gillies, K
- Abstract
OBJECTIVES: To use the Theoretical Domains Framework (TDF) to identify barriers and enablers to participant retention in trials requiring questionnaire return and/or attendance at follow-up clinics. STUDY DESIGN AND SETTING: We invited participants (n = 607) from five pragmatic effectiveness trials, who missed at least one follow-up time point (by not returning a questionnaire and/or not attending a clinic visit), to take part in semistructured telephone interviews. The TDF informed both data collection and analysis. To establish what barriers and enablers most likely influence the target behavior the domain relevance threshold was set at >75% of participants mentioning the domain. RESULTS: Sixteen participants (out of 25 showing interest) were interviewed. Overall, seven theoretical domains were identified as both barriers and enablers to the target behaviors of attending clinic appointments and returning postal questionnaires. Barriers frequently reported in relation to both target behaviours stemmed from participants' knowledge, beliefs about their capabilities and the consequences of performing (or not performing) the behavior. Two domains were identified as salient for questionnaire return only: goals; and memory, attention and decision-making. Emotion was identified as relevant for clinic attendance only. CONCLUSION: This is the first study informed by behavioural science to explore trial participants' accounts of trial retention. Findings will serve as a guiding framework when designing trials to limit barriers and enhance enablers of retention within clinical trials.
- Published
- 2021
20. Tibial nerve stimulation compared with sham to reduce incontinence in care home residents: ELECTRIC RCT
- Author
-
Booth, J, Aucott, L, Cotton, S, Davis, B, Fenocchi, L, Goodman, C, Hagen, S, Harari, D, Lawrence, M, Lowndes, A, Macaulay, L, MacLennan, G, Mason, H, McClurg, D, Norrie, J, Norton, C, O’Dolan, C, Skelton, D, Surr, C, Treweek, S, Booth, J, Aucott, L, Cotton, S, Davis, B, Fenocchi, L, Goodman, C, Hagen, S, Harari, D, Lawrence, M, Lowndes, A, Macaulay, L, MacLennan, G, Mason, H, McClurg, D, Norrie, J, Norton, C, O’Dolan, C, Skelton, D, Surr, C, and Treweek, S
- Abstract
Background Urinary incontinence is prevalent in nursing and residential care homes, and has a profound impact on residents’ dignity and quality of life. Treatment options are limited in these care contexts and care homes predominantly use absorbent pads to contain incontinence, rather than actively treat it. Transcutaneous posterior tibial nerve stimulation is a non-invasive, safe, low-cost intervention that is effective in reducing urinary incontinence in adults. Objective To determine the clinical effectiveness of transcutaneous posterior tibial nerve stimulation to treat urinary incontinence in care home residents and to determine the associated costs of the treatment. Design A multicentre, pragmatic, participant and outcome assessor-blind, randomised placebo-controlled trial. Setting A total of 37 UK residential and nursing care homes. Participants Care home residents with at least weekly urinary incontinence that is contained using absorbent pads and who are able to use a toilet/toilet aid with or without assistance. Interventions Residents were randomised (1 : 1) to receive 12 30-minute sessions of transcutaneous posterior tibial nerve stimulation or sham stimulation over a 6-week period. Main outcome measures Primary outcome – change in volume of urine leaked over a 24-hour period at 6 weeks. Secondary outcomes – number of pads used, Perception of Bladder Condition, toileting skills, quality of life and resource use. Results A total of 408 residents were randomised (transcutaneous posterior tibial nerve stimulation, n = 197; sham stimulation, n = 209); two exclusions occurred post randomisation. Primary outcome data were available for 345 (85%) residents (transcutaneous posterior tibial nerve stimulation, n = 167; sham stimulation, n = 178). Adherence to the intervention protocol was as follows: 78% of the transcutaneous posterior tibial nerve stimulation group and 71% of the sham group received the correct stimulation. Primary intention-to-treat adjusted ana
- Published
- 2021
21. Can the draw of professional football clubs help promote weight loss in overweight and obese men? A feasibility study of the Football Fans in Training programme delivered through the Scottish Premier League
- Author
-
Gray, CM, Hunt, K, Mutrie, N, Anderson, AS, Treweek, S, and Wyke, S
- Published
- 2011
- Full Text
- View/download PDF
22. Recruitment and retention of participants in UK surgical trials: survey of key issues reported by trial staff
- Author
-
Crocker, J C, primary, Farrar, N, additional, Cook, J A, additional, Treweek, S, additional, Woolfall, K, additional, Chant, A, additional, Bostock, J, additional, Locock, L, additional, Rees, S, additional, Olszowski, S, additional, and Bulbulia, R, additional
- Published
- 2020
- Full Text
- View/download PDF
23. National and international networks to improve clinical research methodology
- Author
-
Briel, M, Treweek, S, and Hemkens, L
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Background/research question: High quality clinical research is a pre-requisite for high quality evidence to best inform decision making in clinical practice and health policy. However, clinical research faces many challenges and the evidence base to guide the design and conduct of clinical studies,[for full text, please go to the a.m. URL], Nützliche patientenrelevante Forschung; 21. Jahrestagung des Deutschen Netzwerks Evidenzbasierte Medizin
- Published
- 2020
- Full Text
- View/download PDF
24. PIRRIST: Patient and public involvement (PPI) to enhance recruitment and retention in surgical trials
- Author
-
Crocker, JC, Bostock, J, Treweek, S, Farrar, N, Chant, A, Cook, JA, Kerr, P, Rees, S, Locock, L, Woolfall, K, Olszowski, S, and Bulbulia, R
- Abstract
Meeting abstract from the 5th International Clinical Trials Methodology Conference (ICTMC 2019) https://ictmc2019.com/
- Published
- 2019
25. Direct measurement of the optical properties of human breast skin
- Author
-
Treweek, S. P. and Barbenel, J. C.
- Published
- 1996
- Full Text
- View/download PDF
26. The effect of optimised patient information materials on recruitment in a lung cancer screening trial: an embedded randomised recruitment trial
- Author
-
Parker, A, Knapp, P, Treweek, S, Madurasinghe, V, Littleford, R, Gallant, S, Sullivan, F, Schembri, S, Rick, J, Graffy, J, Collier, DJ, Eldridge, S, Kennedy, A, Bower, P, University of St Andrews. School of Medicine, University of St Andrews. Population and Behavioural Science Division, Parker, Adwoa [0000-0002-2880-3935], and Apollo - University of Cambridge Repository
- Subjects
Male ,Health Knowledge, Attitudes, Practice ,Lung Neoplasms ,Research methodology ,Research Subjects ,NDAS ,SDG 3 - Good Health and Well-being ,Patient Education as Topic ,Predictive Value of Tests ,Biomarkers, Tumor ,Humans ,Early Detection of Cancer ,Aged ,Autoantibodies ,Neoplasm Staging ,Randomised controlled trial ,lcsh:R5-920 ,Incidence ,Patient Selection ,Middle Aged ,Study within a trial (SWAT) ,Correspondence as Topic ,Patient information ,Scotland ,Sample Size ,RA Public aspects of medicine ,Female ,Pamphlets ,Recruitment ,lcsh:Medicine (General) ,Comprehension ,RA - Abstract
The ECLS trial is funded by the Chief Scientist Office of the Scottish Government and Oncimmune Ltd. The MRC START programme is funded by the MRC Methodology Research Programme (grant reference G1002325). Materials relating to the MRC START programme can be found in the protocol and on the University of Manchester website (http://www.population-health.manchester.ac.uk/mrcstart/). The Health Services Research Unit, University of Aberdeen, receives core funding from the Chief Scientist Office of the Scottish Government Health Directorates. Background: Written participant information materials are important for ensuring that potential trial participants receive necessary information so that they can provide informed consent. However, such materials are frequently long and complex, which may negatively impact patient understanding and willingness to participate. Improving readability, ease of comprehension and presentation may assist with improved participant recruitment. The Systematic Techniques for Assisting Recruitment to Trials (MRC START) study aimed to develop and evaluate interventions to improve trial recruitment. This study aimed to assess the effectiveness of an optimised participant information brochure and cover letter developed by MRC START regarding response and participant recruitment rates. Methods: We conducted a study within a trial (SWAT) embedded in the EarlyCDT Lung Cancer Scotland (ECLS) trial that aimed to assess the effectiveness of a new test in reducing the incidence of patients with late-stage lung cancer at diagnosis compared with standard care. Potential participants approached for ECLS were randomised to receive the original participant information brochure and accompanying letter (control group) or optimised versions of these materials which had undergone user testing and a process of re-writing, re-organisation and professional graphic design (intervention group). The primary outcome was the number of patients recruited to ECLS. The secondary outcome was the proportion of patients expressing an interest in participating in ECLS. Results: In total, 2262 patients were randomised, 1136 of whom were sent the intervention materials and 1126 of whom were sent the control materials. The proportion of patients enrolled and randomised into ECLS was 180 of 1136 (15.8%) in the intervention group and 176 of 1126 (15.6%) in the control group (OR = 1.016, 95% CI, 0.660 to 1.564). The proportion of patients who positively responded to the invitation was 224 of 1136 (19.7%) in the intervention group and 205 of 1126 (18.2%) in the control group (OR = 1.103, 95% CI, 0.778 to 1.565). Conclusions: Optimised patient information materials made little difference to the proportion of patients positively responding to a trial invitation or to the proportion subsequently randomised to the host trial. Publisher PDF
- Published
- 2018
- Full Text
- View/download PDF
27. P357 A before-and-after feasibility study of an intervention to increase chest physiotherapy adherence among young children with cystic fibrosis
- Author
-
France, E., primary, Hoskins, G., additional, Hoddinott, P., additional, Hagen, S., additional, Williams, B., additional, Main, E., additional, Treweek, S., additional, Glasscoe, C., additional, Dhouieb, E., additional, Cunningham, S., additional, and Semple, K., additional
- Published
- 2019
- Full Text
- View/download PDF
28. The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial
- Author
-
Wyke, S., Bunn, C., Andersen, E., Silva, M.N., Nassau, F. van, McSkimming, P., Kolovos, S., Gill, J.M., Gray, C.M., Hunt, K., Anderson, A.S., Bosmans, J., Jelsma, J.G., Kean, S., Lemyre, N., Loudon, D.W., Macaulay, L., Maxwell, D.J., McConnachie, A., Mutrie, N., Nijhuis-van der Sanden, M.W.G., Pereira, H.V., Philpott, M., Roberts, G.C., Rooksby, J., Roynesdal, O.B., Sattar, N., Sorensen, M., Teixeira, P.J., Treweek, S., Achterberg, T. van, Glind, I.M. van de, Mechelen, W. van, Ploeg, H.P. van der, Wyke, S., Bunn, C., Andersen, E., Silva, M.N., Nassau, F. van, McSkimming, P., Kolovos, S., Gill, J.M., Gray, C.M., Hunt, K., Anderson, A.S., Bosmans, J., Jelsma, J.G., Kean, S., Lemyre, N., Loudon, D.W., Macaulay, L., Maxwell, D.J., McConnachie, A., Mutrie, N., Nijhuis-van der Sanden, M.W.G., Pereira, H.V., Philpott, M., Roberts, G.C., Rooksby, J., Roynesdal, O.B., Sattar, N., Sorensen, M., Teixeira, P.J., Treweek, S., Achterberg, T. van, Glind, I.M. van de, Mechelen, W. van, and Ploeg, H.P. van der
- Abstract
Contains fulltext : 202275.pdf (publisher's version ) (Open Access), BACKGROUND: Reducing sitting time as well as increasing physical activity in inactive people is beneficial for their health. This paper investigates the effectiveness of the European Fans in Training (EuroFIT) programme to improve physical activity and sedentary time in male football fans, delivered through the professional football setting. METHODS AND FINDINGS: A total of 1,113 men aged 30-65 with self-reported body mass index (BMI) >/=27 kg/m2 took part in a randomised controlled trial in 15 professional football clubs in England, the Netherlands, Norway, and Portugal. Recruitment was between September 19, 2015, and February 2, 2016. Participants consented to study procedures and provided usable activity monitor baseline data. They were randomised, stratified by club, to either the EuroFIT intervention or a 12-month waiting list comparison group. Follow-up measurement was post-programme and 12 months after baseline. EuroFIT is a 12-week, group-based programme delivered by coaches in football club stadia in 12 weekly 90-minute sessions. Weekly sessions aimed to improve physical activity, sedentary time, and diet and maintain changes long term. A pocket-worn device (SitFIT) allowed self-monitoring of sedentary time and daily steps, and a game-based app (MatchFIT) encouraged between-session social support. Primary outcome (objectively measured sedentary time and physical activity) measurements were obtained for 83% and 85% of intervention and comparison participants. Intention-to-treat analyses showed a baseline-adjusted mean difference in sedentary time at 12 months of -1.6 minutes/day (97.5% confidence interval [CI], -14.3-11.0; p = 0.77) and in step counts of 678 steps/day (97.5% CI, 309-1.048; p < 0.001) in favor of the intervention. There were significant improvements in diet, weight, well-being, self-esteem, vitality, and biomarkers of cardiometabolic health in favor of the intervention group, but not in quality of life. There was a 0.95 probability of EuroFIT
- Published
- 2019
29. Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: Protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma
- Author
-
Sub Human-Centered Computing, Dep Scheikunde, Human-Centered Computing, Murchie, P., Masthoff, J., Walter, F. M., Rahman, K., Allan, J. L., Burrows, N., Proby, C., Lee, A. J., Johnston, M., Durrani, A., Depasquale, I., Brant, B., Neilson, A., Meredith, F., Treweek, S., Hall, S., McDonald, A., Sub Human-Centered Computing, Dep Scheikunde, Human-Centered Computing, Murchie, P., Masthoff, J., Walter, F. M., Rahman, K., Allan, J. L., Burrows, N., Proby, C., Lee, A. J., Johnston, M., Durrani, A., Depasquale, I., Brant, B., Neilson, A., Meredith, F., Treweek, S., Hall, S., and McDonald, A.
- Published
- 2019
30. Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma
- Author
-
Murchie, P, Masthoff, J, Walter, FM, Rahman, K, Allan, JL, Burrows, N, Proby, C, Lee, AJ, Johnston, M, Durrani, A, Depasquale, I, Brant, B, Neilson, A, Meredith, F, Treweek, S, Hall, S, McDonald, A, Murchie, P, Masthoff, J, Walter, FM, Rahman, K, Allan, JL, Burrows, N, Proby, C, Lee, AJ, Johnston, M, Durrani, A, Depasquale, I, Brant, B, Neilson, A, Meredith, F, Treweek, S, Hall, S, and McDonald, A
- Abstract
BACKGROUND: Melanoma is common; 15,906 people in the UK were diagnosed with melanoma in 2015 and incidence has increased fivefold in 30 years. Melanoma affects old and young people, with poor prognosis once metastatic. UK guidelines recommend people treated for cutaneous melanoma receive extended outpatient, hospital follow up to detect recurrence or new primaries. Such follow up of the growing population of melanoma survivors is burdensome for both individuals and health services. Follow up is important since approximately 20% of patients with early-stage melanoma experience a recurrence and 4-8% develop a new primary; the risk of either is highest in the first 5 years. Achieving Self-directed Integrated Cancer Aftercare (ASICA) is a digital intervention to increase total-skin-self-examination (TSSE) by people treated for melanoma, with usual follow up. METHODS: We aim to recruit 240 adults with a previous first-stage 0-2C primary cutaneous melanoma, from secondary care in North-East Scotland and the East of England. Participants will be randomised to receive the ASICA intervention (a tablet-based digital intervention to prompt and support TSSE) or control group (treatment as usual). Patient-reported and clinical data will be collected at baseline, including the modified Melanoma Worry Scale (MWS), the Hospital Anxiety and Depression Scale (HADs), the EuroQoL 5-dimension 5-level questionnaire (EQ-5D-5 L), and questions about TSSE practice, intentions, self-efficacy and planning. Participants will be followed up by postal questionnaire at 3, 6 and 12 months following randomization, along with a 12-month review of clinical data. The primary timepoint for outcome analyses will be12 months after randomisation. DISCUSSION: If the ASICA intervention improves the practice of TSSE in those affected by melanoma, this may lead to improved psychological well-being and earlier detection of recurrent and new primary melanoma. This could impact both patients and National Health
- Published
- 2019
31. MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1
- Author
-
Flower, M, Lomeikaite, V, Ciosi, M, Cumming, S, Morales, F, Lo, K, Moss, DH, Jones, L, Holmans, P, Monckton, DG, Tabrizi, SJ, Kraus, P, Hoffman, R, Tobin, A, Borowsky, B, Keenan, S, Whitlock, KB, Quelle, S, Campbell, C, Wang, C, Langbehn, D, Axelson, E, Johnson, H, Acharya, T, Cash, DM, Frost, C, Jones, R, Jurgen, C, t Hart, EP, van Der Grond, J, Witjes-Ane, M-NN, Roos, RAC, Dumas, EM, van den Bogaard, SJA, Stopford, C, Craufurd, D, Callaghan, J, Arran, N, Rosas, DD, Lee, S, Monaco, W, ORegan, A, Milchman, C, Frajman, E, Labuschagne, I, Stout, J, Campbell, M, Andrews, SC, Bechtel, N, Reilmann, R, Bohlen, S, Kennard, C, Berna, C, Hicks, S, Durr, A, Pourchot, C, Bardinet, E, Nigaud, K, Valabregue, R, Lehericy, S, Marelli, C, Jauffret, C, Justo, D, Leavitt, B, Decolongon, J, Sturrock, A, Coleman, A, Santos, RD, Patel, A, Gibbard, C, Whitehead, D, Wild, E, Owen, G, Crawford, H, Malone, I, Lahiri, N, Fox, NC, Hobbs, NZ, Scahill, R, Ordidge, R, Pepple, T, Read, J, Say, MJ, Landwehrmeyer, B, Daidj, FOA, Bassez, G, Lignier, B, Couppey, F, Delmas, S, Deux, J-F, Hankiewicz, K, Dogan, C, Minier, L, Chevalier, P, Hamadouche, A, Catt, M, van Hees, V, Catt, S, Schwalber, A, Dittrich, J, Kierkegaard, M, Wenninger, S, Schoser, B, Schuller, A, Stahl, K, Kiinzel, H, Wolff, M, Jellinek, A, Moreno, CJ, Gorman, G, Lochmuller, H, Trenell, M, van Laar, S, Wood, L, Cassidy, S, Newman, J, Charman, S, Steffaneti, R, Taylor, L, Brownrigg, A, Day, S, Atalaia, A, Raaphorst, J, Okkersen, K, van Engelen, B, Nikolaus, S, Cornelissen, Y, van Nimwegen, M, Maas, D, Klerks, E, Bouman, S, Knoop, H, Heskamp, L, Heerschap, A, Rahmadi, R, Groot, P, Heskes, T, Kapusta, K, Glennon, J, Abghari, S, Aschrafi, A, Poelmans, G, Treweek, S, Hogarth, F, Littleford, R, Donnan, P, Hapca, A, Hannah, M, McKenzie, E, Rauchhaus, P, Cumming, SA, Adam, B, Faber, C, Merkies, I, Flower, M, Lomeikaite, V, Ciosi, M, Cumming, S, Morales, F, Lo, K, Moss, DH, Jones, L, Holmans, P, Monckton, DG, Tabrizi, SJ, Kraus, P, Hoffman, R, Tobin, A, Borowsky, B, Keenan, S, Whitlock, KB, Quelle, S, Campbell, C, Wang, C, Langbehn, D, Axelson, E, Johnson, H, Acharya, T, Cash, DM, Frost, C, Jones, R, Jurgen, C, t Hart, EP, van Der Grond, J, Witjes-Ane, M-NN, Roos, RAC, Dumas, EM, van den Bogaard, SJA, Stopford, C, Craufurd, D, Callaghan, J, Arran, N, Rosas, DD, Lee, S, Monaco, W, ORegan, A, Milchman, C, Frajman, E, Labuschagne, I, Stout, J, Campbell, M, Andrews, SC, Bechtel, N, Reilmann, R, Bohlen, S, Kennard, C, Berna, C, Hicks, S, Durr, A, Pourchot, C, Bardinet, E, Nigaud, K, Valabregue, R, Lehericy, S, Marelli, C, Jauffret, C, Justo, D, Leavitt, B, Decolongon, J, Sturrock, A, Coleman, A, Santos, RD, Patel, A, Gibbard, C, Whitehead, D, Wild, E, Owen, G, Crawford, H, Malone, I, Lahiri, N, Fox, NC, Hobbs, NZ, Scahill, R, Ordidge, R, Pepple, T, Read, J, Say, MJ, Landwehrmeyer, B, Daidj, FOA, Bassez, G, Lignier, B, Couppey, F, Delmas, S, Deux, J-F, Hankiewicz, K, Dogan, C, Minier, L, Chevalier, P, Hamadouche, A, Catt, M, van Hees, V, Catt, S, Schwalber, A, Dittrich, J, Kierkegaard, M, Wenninger, S, Schoser, B, Schuller, A, Stahl, K, Kiinzel, H, Wolff, M, Jellinek, A, Moreno, CJ, Gorman, G, Lochmuller, H, Trenell, M, van Laar, S, Wood, L, Cassidy, S, Newman, J, Charman, S, Steffaneti, R, Taylor, L, Brownrigg, A, Day, S, Atalaia, A, Raaphorst, J, Okkersen, K, van Engelen, B, Nikolaus, S, Cornelissen, Y, van Nimwegen, M, Maas, D, Klerks, E, Bouman, S, Knoop, H, Heskamp, L, Heerschap, A, Rahmadi, R, Groot, P, Heskes, T, Kapusta, K, Glennon, J, Abghari, S, Aschrafi, A, Poelmans, G, Treweek, S, Hogarth, F, Littleford, R, Donnan, P, Hapca, A, Hannah, M, McKenzie, E, Rauchhaus, P, Cumming, SA, Adam, B, Faber, C, and Merkies, I
- Abstract
The mismatch repair gene MSH3 has been implicated as a genetic modifier of the CAG·CTG repeat expansion disorders Huntington's disease and myotonic dystrophy type 1. A recent Huntington's disease genome-wide association study found rs557874766, an imputed single nucleotide polymorphism located within a polymorphic 9 bp tandem repeat in MSH3/DHFR, as the variant most significantly associated with progression in Huntington's disease. Using Illumina sequencing in Huntington's disease and myotonic dystrophy type 1 subjects, we show that rs557874766 is an alignment artefact, the minor allele for which corresponds to a three-repeat allele in MSH3 exon 1 that is associated with a reduced rate of somatic CAG·CTG expansion (P = 0.004) and delayed disease onset (P = 0.003) in both Huntington's disease and myotonic dystrophy type 1, and slower progression (P = 3.86 × 10-7) in Huntington's disease. RNA-Seq of whole blood in the Huntington's disease subjects found that repeat variants are associated with MSH3 and DHFR expression. A transcriptome-wide association study in the Huntington's disease cohort found increased MSH3 and DHFR expression are associated with disease progression. These results suggest that variation in the MSH3 exon 1 repeat region influences somatic expansion and disease phenotype in Huntington's disease and myotonic dystrophy type 1, and suggests a common DNA repair mechanism operates in both repeat expansion diseases.
- Published
- 2019
32. Designing and using incentives to support recruitment and retention in clinical trials: a scoping review and a checklist for design.
- Author
-
Parkinson, B, Meacock, R, Sutton, M, Fichera, E, Mills, N, Shorter, GW, Treweek, S, Harman, NL, Brown, RCH, Gillies, K, Bower, P, Parkinson, B, Meacock, R, Sutton, M, Fichera, E, Mills, N, Shorter, GW, Treweek, S, Harman, NL, Brown, RCH, Gillies, K, and Bower, P
- Abstract
BACKGROUND: Recruitment and retention of participants are both critical for the success of trials, yet both remain significant problems. The use of incentives to target participants and trial staff has been proposed as one solution. The effects of incentives are complex and depend upon how they are designed, but these complexities are often overlooked. In this paper, we used a scoping review to 'map' the literature, with two aims: to develop a checklist on the design and use of incentives to support recruitment and retention in trials; and to identify key research topics for the future. METHODS: The scoping review drew on the existing economic theory of incentives and a structured review of the literature on the use of incentives in three healthcare settings: trials, pay for performance, and health behaviour change. We identified the design issues that need to be considered when introducing an incentive scheme to improve recruitment and retention in trials. We then reviewed both the theoretical and empirical evidence relating to each of these design issues. We synthesised the findings into a checklist to guide the design of interventions using incentives. RESULTS: The issues to consider when designing an incentive system were summarised into an eight-question checklist. The checklist covers: the current incentives and barriers operating in the system; who the incentive should be directed towards; what the incentive should be linked to; the form of incentive; the incentive size; the structure of the incentive system; the timing and frequency of incentive payouts; and the potential unintended consequences. We concluded the section on each design aspect by highlighting the gaps in the current evidence base. CONCLUSIONS: Our findings highlight how complex the design of incentive systems can be, and how crucial each design choice is to overall effectiveness. The most appropriate design choice will differ according to context, and we have aimed to provide context-specific
- Published
- 2019
33. ELECtric Tibial nerve stimulation to Reduce Incontinence in Care homes: protocol for the ELECTRIC randomised trial
- Author
-
Booth, J, Aucott, L, Cotton, C, Goodman, C, Hagen, S, Harari, D, Lawrence, M, Lowndes, A, Macaulay, L, MacLennan, G, Mason, H, McClurg, D, Norrie, J, Norton, C, O'Dolon, C, Skelton, DA, Surr, C, Treweek, S, Booth, J, Aucott, L, Cotton, C, Goodman, C, Hagen, S, Harari, D, Lawrence, M, Lowndes, A, Macaulay, L, MacLennan, G, Mason, H, McClurg, D, Norrie, J, Norton, C, O'Dolon, C, Skelton, DA, Surr, C, and Treweek, S
- Abstract
Background Urinary incontinence (UI) is highly prevalent in nursing and residential care homes (CH) and profoundly impacts on residents’ dignity and quality of life. Care homes predominantly use absorbent pads to contain UI rather than actively treat the condition. Transcutaneous posterior tibial nerve stimulation (TPTNS) is a non-invasive, safe, low-cost intervention with demonstrated effectiveness for reducing UI in adults. However, the effectiveness of TPTNS to treat UI in older adults living in care homes is not known. The ELECTRIC Trial aims to establish if a programme of TPTNS is a clinically effective treatment for UI in care home residents and investigate the associated costs and consequences. Methods This is a pragmatic, multicentre, placebo controlled randomised parallel group trial comparing effectiveness of TPTNS (target n=250) with sham stimulation (target n=250) in reducing volume of UI in CH residents. CH residents (men and women) with self- or staff- reported UI of more than once per week are eligible to take part, including those with cognitive impairment. Outcomes will be measured at 6, 12 and 18 weeks post randomisation using the following measures: 24-hour pad weight tests (PWT), post void residual urine (bladder scans), Patient Perception of Bladder Condition (PPBC), Minnesota Toileting Skills Questionnaire (MTSQ) and Dementia Quality of Life (DEMQOL). Economic evaluation based on a bespoke Resource Use Questionnaire will assess the costs of providing a programme of TPTNS. A concurrent process evaluation will investigate fidelity to the intervention and influencing factors and qualitative interviews will explore the experiences of TPTNS from the perspective of CH residents, family members, CH staff and managers. Discussion TPTNS is a non-invasive intervention that has demonstrated effectiveness in reducing UI in adults. The ELECTRIC Trial will involve CH staff delivering TPTNS to residents and establish whether TPTNS is more effective than sham
- Published
- 2019
34. Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: Protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma
- Author
-
Murchie, Peter, primary, Masthoff, J, additional, Walter, FM, additional, Rahman, K, additional, Allan, JL, additional, Burrows, N, additional, Proby, C, additional, Lee, AJ, additional, Johnston, M, additional, Durrani, A, additional, Depasquale, I, additional, Brant, B, additional, Neilson, A, additional, Meredith, F, additional, Treweek, S, additional, Hall, S, additional, and McDonald, A, additional
- Published
- 2019
- Full Text
- View/download PDF
35. #3 PIRRIST: A patient and public involvement (PPI) intervention to enhance recruitment and retention in surgical trials (oral presentation)
- Author
-
Crocker, J., primary, Rees, S., additional, Locock, L., additional, Petit-Zeman, S., additional, Chant, A., additional, Treweek, S., additional, Cook, J., additional, Farrar, N., additional, Woolfall, K., additional, Bostock, J., additional, Harmston, R., additional, Ferrey, A., additional, and Bulbulia, R., additional
- Published
- 2018
- Full Text
- View/download PDF
36. Cognitive behavioural therapy with optional graded exercise therapy in patients with severe fatigue with myotonic dystrophy type 1: a multicentre, single-blind, randomised trial
- Author
-
Okkersen, K., Jimenez-Moreno, Cecilia, Wenninger, S., Daidj, Ferroudja, Glennon, J.C., Cumming, S.A., Knoop, H., Heerschap, A., Treweek, S., Engelen, B.G.M. van, Okkersen, K., Jimenez-Moreno, Cecilia, Wenninger, S., Daidj, Ferroudja, Glennon, J.C., Cumming, S.A., Knoop, H., Heerschap, A., Treweek, S., and Engelen, B.G.M. van
- Abstract
Item does not contain fulltext
- Published
- 2018
37. 2nd TwiCs symposium summary
- Author
-
Relton, C., Burbach, M., Collett, C., Flory, J., Gerlich, S., Holm, S., Hunn, A., Kim, S.Y., Kwakkenbos, L., May, A., Nicholl, J., Young-Afat, D., Treweek, S., Uher, R., Staa, T.P. van, Velden, J. van der, Verkooijen, H.M., Vickers, A., Welch, S., and Zwarenstein, M.
- Subjects
Experimental Psychopathology and Treatment - Abstract
Contains fulltext : 219689.pdf (Publisher’s version ) (Open Access) On 7-8th November 2016, 60 people with an interest in the 'Trials within Cohorts' (TwiCs) approach for randomised controlled trial design met in London. The purpose of this 2nd TwiCs international symposium was to share perspectives and experiences on ethical aspects of the TwiCs design, discuss how TwiCs relate to the current ethical framework, provide a forum in which to discuss and debate ethical issues and identify future directions for conceptual and empirical research. The symposium was supported by the Wellcome Trust and the NIHR CLAHRC Yorkshire and Humber and organised by members of the TwiCs network led by Clare Relton and attended by people from the UK, the Netherlands, Norway, Canada and USA. The two-day symposium enabled an international group to meet and share experiences of the TwiCs design (also known as the 'cohort multiple RCT design'), and to discuss plans for future research. Over the two days, invited plenary talks were interspersed by discussions, posters and mini presentations from bioethicists, triallists and health research regulators. Key findings of the symposium were: (1) It is possible to make a compelling case to ethics committees that TwiCs designs are appropriate and ethical; (2) The importance of wider considerations around the ethics of inefficient trial designs; and (3) some questions about the ethical requirements for content and timing of informed consent for a study using the TwiCs design need to be decided on a case-by-case basis. 3 p.
- Published
- 2017
38. Strategies to improve recruitment to research studies
- Author
-
Treweek, S, Pitkethly, M, Cook, JAC, Kjeldstrom, M, Taskil, T, Johansen, M, Sullivan, F, Wilson, S, Jackson, C, Jones, R, and Mitchell, E
- Abstract
BACKGROUND: Recruiting participants to trials can be extremely difficult. Identifying strategies that improve trial recruitment would benefit both trialists and health research. OBJECTIVES: To quantify the effects of strategies to improve recruitment of participants to randomised controlled trials. SEARCH STRATEGY: We searched the Cochrane Methodology Review Group Specialised Register - CMR (The Cochrane Library (online) Issue 1 2008) (searched 20 February 2008); MEDLINE, Ovid (1950 to date of search) (searched 06 May 2008); EMBASE, Ovid (1980 to date of search) (searched 16 May 2008); ERIC, CSA (1966 to date of search) (searched 19 March 2008); Science Citation Index Expanded, ISI Web of Science (1975 to date of search) (searched 19 March 2008); Social Sciences Citation Index, ISI Web of Science (1975 to date of search) (searched 19 March 2008); and National Research Register (online) (Issue 3 2007) (searched 03 September 2007); C2-SPECTR (searched 09 April 2008). We also searched PubMed (25 March 2008) to retrieve "related articles" for 15 studies included in a previous version of this review. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials of methods to increase recruitment to randomised controlled trials. This includes non-healthcare studies and studies recruiting to hypothetical trials. Studies aiming to increase response rates to questionnaires or trial retention, or which evaluated incentives and disincentives for clinicians to recruit patients were excluded. DATA COLLECTION AND ANALYSIS: Data were extracted on the method evaluated; country in which the study was carried out; nature of the population; nature of the study setting; nature of the study to be recruited into; randomisation or quasi-randomisation method; and numbers and proportions in each intervention group. We used risk ratios and their 95% confidence intervals to describe the effects in individual trials, and assessed heterogeneity of these ratios between trials. MAIN RESULTS: We identified 27 eligible trials with more than 26,604 participants. There were 24 studies involving interventions aimed directly at trial participants, while three evaluated interventions aimed at people recruiting participants. All studies were in health care. Some interventions were effective in increasing recruitment: telephone reminders to non-respondents (RR 2.66, 95% CI 1.37 to 5.18), use of opt-out, rather than opt-in, procedures for contacting potential trial participants (RR 1.39, 95% CI 1.06 to 1.84) and open designs where participants know which treatment they are receiving in the trial (RR 1.25, 95% CI 1.18 to 1.34). However, some of these strategies have disadvantages, which may limit their widespread use. For example, opt-out procedures are controversial and open designs are by definition unblinded. The effects of many other recruitment strategies are unclear; examples include the use of video to provide trial information to potential participants and modifying the training of recruiters. Many studies looked at recruitment to hypothetical trials and it is unclear how applicable these results are to real trials. AUTHORS' CONCLUSIONS: Trialists can increase recruitment to their trials by using the strategies shown to be effective in this review: telephone reminders; use of opt-out, rather than opt-in; procedures for contacting potential trial participants and open designs. Some strategies (e.g. open trial designs) need to be considered carefully before use because they also have disadvantages. For example, opt-out procedures are controversial and open designs are by definition unblinded.
- Published
- 2016
- Full Text
- View/download PDF
39. Guidelines for reporting embedded recruitment trials
- Author
-
Madurasinghe, VW, Eldridge, S, Bower, P, Hughes-Morley, A, Collier, D, Forbes, G, Graffy, J, Kennedy, A, Knapp, P, Rick, J, Salisbury, C, Small, N, Torgerson, D, Treweek, S, Montgomery, AA, Dack, C, Shanahan, DR, Reeves, D, Cook, Jonathan, Campbell, M, and Brueton, V
- Subjects
medicine.medical_specialty ,Population ,Psychological intervention ,MEDLINE ,Alternative medicine ,Medicine (miscellaneous) ,Guidelines as Topic ,Random Allocation ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Pharmacology (medical) ,030212 general & internal medicine ,education ,Clinical Trials as Topic ,education.field_of_study ,business.industry ,Patient Selection ,Research ,Methodology ,Consolidated Standards of Reporting Trials ,Reporting guidelines ,Primary care ,Checklist ,3. Good health ,Test (assessment) ,Clinical trial ,Family medicine ,Embedded randomised controlled trial ,Recruitment ,business ,030217 neurology & neurosurgery - Abstract
Background Recruitment to clinical trials is difficult with many trials failing to recruit to target and within time. Embedding trials of recruitment interventions within host trials may provide a successful way to improve this. There are no guidelines for reporting such embedded methodology trials. As part of the Medical Research Council funded Systematic Techniques for Assisting Recruitment to Trials (MRC START) programme designed to test interventions to improve recruitment to trials, we developed guidelines for reporting embedded trials. Methods We followed a three-phase guideline development process: (1) pre-meeting literature review to generate items for the reporting guidelines; (2) face-to-face consensus meetings to draft the reporting guidelines; and (3) post-meeting feedback review, and pilot testing, followed by finalisation of the reporting guidelines. Results We developed a reporting checklist based on the Consolidated Standards for Reporting Trials (CONSORT) statement 2010. Embedded trials evaluating recruitment interventions should follow the CONSORT statement 2010 and report all items listed as essential. We used a number of examples to illustrate key issues that arise in embedded trials and how best to report them, including (a) how to deal with description of the host trial; (b) the importance of describing items that may differ in the host and embedded trials (such as the setting and the eligible population); and (c) the importance of identifying clearly the point at which the recruitment interventions were embedded in the host trial. Conclusions Implementation of these guidelines will improve the quality of reports of embedded recruitment trials while advancing the science, design and conduct of embedded trials as a whole. Electronic supplementary material The online version of this article (doi:10.1186/s13063-015-1126-y) contains supplementary material, which is available to authorized users.
- Published
- 2016
- Full Text
- View/download PDF
40. The intervention process in the European Fans in Training (EuroFIT) trial: a mixed method protocol for evaluation
- Author
-
van de Glind, I., primary, Bunn, C., additional, Gray, C. M., additional, Hunt, K., additional, Andersen, E., additional, Jelsma, J., additional, Morgan, H., additional, Pereira, H., additional, Roberts, G., additional, Rooksby, J., additional, Røynesdal, Ø., additional, Silva, M., additional, Sorensen, M., additional, Treweek, S., additional, van Achterberg, T., additional, van der Ploeg, H., additional, van Nassau, F., additional, Nijhuis-van der Sanden, M., additional, and Wyke, S., additional
- Published
- 2017
- Full Text
- View/download PDF
41. The intervention process in the European Fans in Training (EuroFIT) trial: a mixed method protocol for evaluation
- Author
-
Glind, I.M. van de, Bunn, C., Gray, C.M., Hunt, K., Andersen, E., Jelsma, J., Morgan, H., Pereira, H., Roberts, G., Rooksby, J., Roynesdal, O., Silva, M., Sorensen, M., Treweek, S., Achterberg, T. van, Ploeg, H. van der, Nassau, F. van, Nijhuis-van der Sanden, M.W.G., Wyke, S., Glind, I.M. van de, Bunn, C., Gray, C.M., Hunt, K., Andersen, E., Jelsma, J., Morgan, H., Pereira, H., Roberts, G., Rooksby, J., Roynesdal, O., Silva, M., Sorensen, M., Treweek, S., Achterberg, T. van, Ploeg, H. van der, Nassau, F. van, Nijhuis-van der Sanden, M.W.G., and Wyke, S.
- Abstract
Contains fulltext : 176939.pdf (publisher's version ) (Open Access), BACKGROUND: EuroFIT is a gender-sensitised, health and lifestyle program targeting physical activity, sedentary time and dietary behaviours in men. The delivery of the program in football clubs, led by the clubs' community coaches, is designed to both attract and engage men in lifestyle change through an interest in football or loyalty to the club they support. The EuroFIT program will be evaluated in a multicentre pragmatic randomised controlled trial (RCT), for which ~1000 overweight men, aged 30-65 years, will be recruited in 15 top professional football clubs in the Netherlands, Norway, Portugal and the UK. The process evaluation is designed to investigate how implementation within the RCT is achieved in the various football clubs and countries and the processes through which EuroFIT affects outcomes. METHODS: This mixed methods evaluation is guided by the Medical Research Council (MRC) guidance for conducting process evaluations of complex interventions. Data will be collected in the intervention arm of the EuroFIT trial through: participant questionnaires (n = 500); attendance sheets and coach logs (n = 360); observations of sessions (n = 30); coach questionnaires (n = 30); usage logs from a novel device for self-monitoring physical activity and non-sedentary behaviour (SitFIT); an app-based game to promote social support for physical activity outside program sessions (MatchFIT); interviews with coaches (n = 15); football club representatives (n = 15); and focus groups with participants (n = 30). Written standard operating procedures are used to ensure quality and consistency in data collection and analysis across the participating countries. Data will be analysed thematically within datasets and overall synthesis of findings will address the processes through which the program is implemented in various countries and clubs and through which it affects outcomes, with careful attention to the context of the football club. DISCUSSION: The process evaluation will
- Published
- 2017
42. Study protocol of European Fans in Training (EuroFIT): a four-country randomised controlled trial of a lifestyle program for men delivered in elite football clubs
- Author
-
Nassau, F. van, Ploeg, H.P. van der, Abrahamsen, F., Andersen, E., Anderson, A.S., Bosmans, J.E., Bunn, C., Chalmers, M., Clissmann, C., Gill, J.M., Gray, C.M., Hunt, K., Jelsma, J.G., Guardia, J.G. La, Lemyre, P.N., Loudon, D.W., Macaulay, L., Maxwell, D.J., McConnachie, A., Martin, A., Mourselas, N., Mutrie, N., Nijhuis-van der Sanden, M.W.G., O'Brien, K., Pereira, H.V., Philpott, M., Roberts, G.C., Rooksby, J., Rost, M., Roynesdal, O., Sattar, N., Silva, M.N., Sorensen, M., Teixeira, P.J., Treweek, S., Achterberg, T. van, Glind, I. van de, Mechelen, W. van, Wyke, S., Nassau, F. van, Ploeg, H.P. van der, Abrahamsen, F., Andersen, E., Anderson, A.S., Bosmans, J.E., Bunn, C., Chalmers, M., Clissmann, C., Gill, J.M., Gray, C.M., Hunt, K., Jelsma, J.G., Guardia, J.G. La, Lemyre, P.N., Loudon, D.W., Macaulay, L., Maxwell, D.J., McConnachie, A., Martin, A., Mourselas, N., Mutrie, N., Nijhuis-van der Sanden, M.W.G., O'Brien, K., Pereira, H.V., Philpott, M., Roberts, G.C., Rooksby, J., Rost, M., Roynesdal, O., Sattar, N., Silva, M.N., Sorensen, M., Teixeira, P.J., Treweek, S., Achterberg, T. van, Glind, I. van de, Mechelen, W. van, and Wyke, S.
- Abstract
Contains fulltext : 171556.pdf (publisher's version ) (Open Access), BACKGROUND: Lifestyle interventions targeting physical activity, sedentary time and dietary behaviours have the potential to initiate and support behavioural change and result in public health gain. Although men have often been reluctant to engage in such lifestyle programs, many are at high risk of several chronic conditions. We have developed an evidence and theory-based, gender sensitised, health and lifestyle program (European Fans in Training (EuroFIT)), which is designed to attract men through the loyalty they feel to the football club they support. This paper describes the study protocol to evaluate the effectiveness and cost-effectiveness of the EuroFIT program in supporting men to improve their level of physical activity and reduce sedentary behaviour over 12 months. METHODS: The EuroFIT study is a pragmatic, two-arm, randomised controlled trial conducted in 15 football clubs in the Netherlands, Norway, Portugal and the UK (England). One-thousand men, aged 30 to 65 years, with a self-reported Body Mass Index (BMI) >/=27 kg/m(2) will be recruited and individually randomised. The primary outcomes are objectively-assessed changes in total physical activity (steps per day) and total sedentary time (minutes per day) at 12 months after baseline assessment. Secondary outcomes are weight, BMI, waist circumference, resting systolic and diastolic blood pressure, cardio-metabolic blood biomarkers, food intake, self-reported physical activity and sedentary time, wellbeing, self-esteem, vitality and quality of life. Cost-effectiveness will be assessed and a process evaluation conducted. The EuroFIT program will be delivered over 12 weekly, 90-minute sessions that combine classroom discussion with graded physical activity in the setting of the football club. Classroom sessions provide participants with a toolbox of behaviour change techniques to initiate and sustain long-term lifestyle changes. The coaches will receive two days of training to enable them to create a posi
- Published
- 2016
43. Developing a patient and public involvement intervention to enhance recruitment and retention in UK surgical trials (PIRRIST)
- Author
-
Crocker, J.C., primary, Rees, S., additional, Locock, L., additional, Petit-Zeman, S., additional, Chant, A., additional, Treweek, S., additional, Cook, J.A., additional, Farrar, N., additional, Woolfall, K., additional, Bostock, J., additional, Bowman, L., additional, and Bulbulia, R., additional
- Published
- 2016
- Full Text
- View/download PDF
44. Matching trial design decisions to the needs of those you hope will use the results: The PRECIS-2 tool
- Author
-
Loudon, K., primary, Zwarenstein, M., additional, Sullivan, F., additional, Donnan, P., additional, and Treweek, S., additional
- Published
- 2016
- Full Text
- View/download PDF
45. S132 A randomised controlled study of lung cancer screening in scotland using the detection of autoantibodies to tumour antigens (earlycdt-lung test)
- Author
-
Dorward, A, primary, Mair, F Frances, additional, Sullivan, F, additional, Vedhara, K, additional, Kendrick, D, additional, Treweek, S, additional, McCowan, C, additional, McConnachie, A, additional, Sproule, M, additional, Briggs, A, additional, Ritchie, L, additional, Milroy, R, additional, Taylor, T, additional, Littleford, R, additional, Brewster, D, additional, and Schembri, S, additional
- Published
- 2016
- Full Text
- View/download PDF
46. #15 Applying the IDEAL framework to a methodological complex intervention (PIRRIST) (poster presentation)
- Author
-
Crocker, J., Farrar, N., Treweek, S., Petit-Zeman, S., Chant, A., Bostock, J., Woolfall, K., Locock, Rees, S., and Bulbulia, R.
- Published
- 2018
- Full Text
- View/download PDF
47. Creating clinical practice guidelines we can trust, use, and share: a new era is imminent
- Author
-
Vandvik, PO, Brandt, L, Alonso-Coello, P, Treweek, S, Akl, EA, Kristiansen, A, Fog-Heen, A, Agoritsas, T, Montori, VM, and Guyatt, G
- Subjects
Publishing ,Internet ,Evidence-Based Medicine ,Quality Assurance, Health Care ,Interprofessional Relations ,Decision Making ,Authorship ,Decision Support Techniques ,User-Computer Interface ,Practice Guidelines as Topic ,ddc:618.97 ,Humans ,Diffusion of Innovation ,Practice Guidelines as Topic/standards - Abstract
Standards and guidance for developing trustworthy clinical practice guidelines are now available, and a number of leading guidelines adhere to the key standards. Even current trustworthy guidelines, however, generally suffer from a cumbersome development process, suboptimal presentation formats, inefficient dissemination to clinicians at the point of care, high risk of becoming quickly outdated, and suboptimal facilitation of shared decision-making with patients. To address these limitations, we have--in our innovative research program and nonprofit organization, MAGIC (Making GRADE the Irresistible Choice)--constructed a conceptual framework and tools to facilitate the creation, dissemination, and dynamic updating of trustworthy guidelines. We have developed an online application that constitutes an authoring and publication platform that allows guideline content to be written and structured in a database, published directly on our web platform or exported in a computer-interpretable language (eg, XML) enabling dissemination through a wide range of outputs that include electronic medical record systems, web portals, and applications for smartphones/tablets. Modifications in guidelines, such as recommendation updates, will lead to automatic alterations in these outputs with minimal additional labor for guideline authors and publishers, greatly facilitating dynamic updating of guidelines. Semiautomated creation of a new generation of decision aids linked to guideline recommendations should facilitate face-to-face shared decision-making in the clinical encounter. We invite guideline organizations to partner with us (www.magicproject.org) to apply and further improve the tools for their purposes. This work will result in clinical practice guidelines that we cannot only trust, but also easily share and use.
- Published
- 2013
48. Implementing evidence-based guideline recommendations: progress with the DECIDE project
- Author
-
Harbour, R. and Treweek, S.
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Background: DECIDE [link:http://www.decide-collaboration.eu/#http://www.decide-collaboration.eu/] is a 5-year project funded by the EU FP7 programme. Now in its 2nd year, the aim is to develop and evaluate methods that improve the dissemination of evidence-based[for full text, please go to the a.m. URL], G-I-N Conference 2012
- Published
- 2012
49. I Always Knew I had the Fitness in Me, It Was Just Getting it Oot was the Pain: Can Professional Football Clubs Help Fans Become More Active?
- Author
-
Gray, C.M., Mutrie, N., Anderson, A.S., Hunt, K., Treweek, S., and Wyke, S.
- Subjects
RA0421 - Published
- 2012
50. MAGIC (Making GRADE the Irresistible Choice): Research program for optimal authoring, dissemination and dynamic updating of electronically structured GRADE guidelines
- Author
-
Vandvik, PO, Brandt, L, Kristiansen, A, Lie, ØH, Akl, E, Alonso, P, Treweek, S, and Guyatt, G
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Background: The GRADE methodology facilitates a systematic and transparent process for evaluating and reporting quality of research evidence and for moving from evidence to recommendations in guideline development. It is equally important to facilitate authoring, maintenance and use of guidelines at[for full text, please go to the a.m. URL], G-I-N Conference 2012
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.